# Ming Fang

> Ming Fang is a seed investor at Redmile Group backing Medical and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Redmile Group](https://shizune.co/investors/profile/redmile-group)
- Location: San Francisco Bay Area, United States
- Total investments: 1
- Last investment: Nov 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/xiaomingfang
- X (Twitter): https://twitter.com/xmingf
- Website: https://x.com/xmingf

Ming Fang is a seed investor at Redmile Group in San Francisco Bay Area focused on Medical and Biotechnology. Ming Fang is based out of San Francisco Bay Area, California, and is the Managing Director of Redmile Group. Ming previously worked at Safeguard Scientifics as a Investor. Ming Fang attended the Wharton School of the University of Pennsylvania.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Home Biosciences | Home Biosciences is a European venture builder dedicated to biotech. | $15M | Seed | Nov 09, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Sofinnova Partners](https://shizune.co/investors/profile/sofinnova-partners) — VC Fund, 1 deal together

## About Redmile Group

VC Fund · San Francisco, United States

Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.

4 contacts available at Redmile Group.

| Name | Title | Profile |
| --- | --- | --- |
| Robert Faulkner | Managing Director | https://shizune.co/investors/profile/rob-faulkner |
| Gerard van Hamel Platerink | Managing Director | https://shizune.co/investors/profile/gerard-van-hamel-platerink |
| Mike Lee | Managing Director/Co-Founder | https://shizune.co/investors/profile/mike-lee-4280 |
| Ming Fang | Managing Director | https://shizune.co/investors/profile/ming-fang |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ming Fang invest in?

Ming Fang invests primarily in Medical and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ming Fang last invest?

The most recent investment recorded for Ming Fang closed in Nov 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co